Stein Gold L, Gottlieb AB, Armstrong AW, Alkousakis T, et al. SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement. Br J Dermatol 2025 Aug 28:ljaf327. doi: 10.1093.
PMID: 40875818